To define the influence of AKT activation on the proliferation of HCC cell lines, we first analyzed the dose-dependent effect of LY294002 on the active phosphorylated form of AKT in Mahlavu cells. The gene discussed is AKT1; the disease is hepatocellular carcinoma.